CVS Health (NYSE:CVS) EVP Prem Shah Acquires 23,855 Shares of Company Stock

CVS Health Corporation (NYSE:CVS – Get Free Report) EVP Prem Shah purchased 23,855 shares of the firm’s stock in a transaction that occurred on Friday, November 6th. The stock was bought at an average cost of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the purchase, the executive vice president directly owned 88,516 shares in the company, valued at $7,425,607.24. This represents a 36.89% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

CVS Health Stock Up 3.0%

CVS stock opened at $83.76 on Friday. The company’s 50 day simple moving average is $90.37 and its 200-day simple moving average is $88.89. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The firm has a market capitalization of $107.12 billion, a PE ratio of 9.75, a P/E/G ratio of 0.82 and a beta of 0.58. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68.

CVS Health (NYSE:CVS – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.65 by $0.44. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm had revenue of $108.40 billion for the quarter, compared to analysts’ expectations of $104.72 billion. During the same period in the previous year, the company posted $1.60 earnings per share. CVS Health’s revenue was up 5.4% compared to the same quarter last year. Equities analysts expect that CVS Health Corporation will post 8.26 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, November 2nd. Investors of record on Thursday, October 22nd were issued a dividend of $0.6650 per share. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.2%. CVS Health’s dividend payout ratio is 30.97%.

Hedge Funds Weigh In On CVS Health

Several institutional investors have recently bought and sold shares of CVS. Kilter Group LLC purchased a new stake in shares of CVS Health during the second quarter valued at $27,000. J.Safra Asset Management Corp purchased a new stake in CVS Health in the 2nd quarter worth approximately $30,000. Beaird Harris Wealth Management LLC lifted its position in CVS Health by 201.0% during the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 195 shares in the last quarter. Timbuktu Capital Management LLC bought a new position in shares of CVS Health in the 2nd quarter worth about $31,000. Finally, Dunhill Financial LLC bought a new stake in shares of CVS Health in the 2nd quarter worth approximately $32,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the company. Cantor Fitzgerald restated a “neutral” rating on shares of CVS Health in a research report on Friday, October 9th. JPMorgan Chase & Co. increased their price target on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Robert W. Baird set a $107.00 price objective on CVS Health in a report on Thursday, August 6th. Evercore reissued an “outperform” rating on shares of CVS Health in a research note on Wednesday. Finally, Argus raised their price target on CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research report on Wednesday, August 19th. Twenty-two analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $108.25.

View Our Latest Research Report on CVS Health

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

  • Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
  • Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
  • Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
  • Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
  • Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage

CVS Health Company Profile

(Get Free Report)

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.

Featured Stories

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.